| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.008 | 0.9 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.02 | 0.9 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.024 | 0.9 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.0069 | 0.9 |